Graft-versus-host reaction (GVHR) following allogeneic bone marrow (BM) transplantation was investigated by analyzing expression of antigen receptors on T cells specific for recipient antigens. GVHR chimeras were prepared by transplanting mixtures of splenic T cells and T-cell-depleted BM cells from B10 (I-E-, Mls-1") or B1O.AQR (I-E+, Mls-lb) mice into lethally irradiated AKR/J (I-E+, Mls-1a) recipients.
Increased proportions of Vp6' T cells reactive to recipient antigens (I-E and Mls-1la) were observed in thymuses from such chimeras 1 or 5 wk after BM transplantation. Vp6' T cells observed 1 wk after BM transplantation were derived from mature T cells that had been inoculated into recipients. These cells responded to recipient antigens expressed in the thymus.
After 5 wk, thymocytes brightly positive for Vp6+ were shown not to descend from mature T cells but to differentiate from precursor cells present in the BM inocula. Since Vp6' T cells were eliminated in thymuses from non-GVHR chimeras 5 wk after BM transplantation using T-cell-depleted BM cells alone, it appears that GVHR occurring in the thymus at an early stage abrogates thymic stromal functions essential to induction of self-tolerance in the T-cell repertoire. These findings propose a mechanism (autoimmunity) to explain in part the pathogenesis of chronic GVHR.
Graft-versus-host reaction (GVHR) has assumed importance with the expanding use of allogeneic bone marrow transplantation (ABMT) to treat diseases for which no alternative therapy exists (1) (2) (3) (4) . GVHR occurs when mature T cells in the bone marrow (BM) graft react immunologically against histocompatibility antigens of recipient type (5) (6) (7) (8) (9) . GVHR may have diverse features, depending upon the genetics of donor and recipient, cell populations of donor, and recipient antigen systems (10, 11) . Donor CD4+ and CD8+ T cells respond vigorously to antigens of recipient (5, 6, 12) , although these two subsets may play different roles in the pathogenesis of GVHR (6, 12, 13) and may also influence each other (12, 14) . Despite the development of reagents for definition of T-cell subsets, analysis of GVHR in the combined histopathological and cellular-immunological perspective is hampered by difficulty in determining whether proliferating lymphocytes in different lymphoid regions represent immunologic reactions or whether this lymphoid proliferation merely reflects physiological lymphopoiesis in situ. Another difficulty is the complexity of processes that underlie histopathological changes observed in the lymphoid tissues (15, 16) . It has been argued, for example, that during GVHR, stress-induced activation of the pituitary-adrenal axis may lead to hypersecretion of corticosteroid hormones and to thymic involution (17) . To simplify further study of GVHR, we sought to determine whether thymus is a direct target of GVHR.
MATERIALS AND METHODS
Mice. AKR/J (AKR) (H-2k, Mls-la) were obtained from The Jackson Laboratory; C57BL/10 (B10) (H-2b, Mls-lb) (AQR), and BlO.BR(BR) (H-2k, Mls-lb) mice were purchased from Shizuoka, Hamamatsu, Japan. B10.AQR (AQR) (H-2y', Mls-lb), [B10 x BlO.A(4R) (H-2h4, Mls-lb)]F1 (B10 x 4R)F1, and (B10 x AQR)F1 mice were maintained at Hokkaido University.
ABMT. Irradiation chimeras were prepared as described (18) . BM cells were treated with anti-Thyl.2 (F7D5, Olac, Bichester, U.K.) plus selected rabbit C prior to i.v. injection of 2.5 x 107 cells into recipient mice after lethal [1000 R (0.258 mC/kg)] total body irradiation (36 R/min). GVHR chimeras were prepared by reconstituting irradiated AKR mice with a mixture of T-cell-depleted BM cells and nylonwool-purified splenic T cells from various strains.
Surface Marker Analysis. Fluorescence-activated cell sorter (FACS) analysis was carried out according to Arase et al. (19) . Thymuses and spleens were removed from chimeras 1 or 5 wk following ABMT. Thymocytes were treated with different monoclonal antibodies: 2C11 (anti-E chain of the CD3 complex), F23. tTo whom reprint requests should be addressed.
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Immunohistology. Immunohistological examination was as described by van given T-cell-depleted B10 BM alone (control recipients) showed no signs of GVHR (8, 9, 18, 19, (22) (23) (24) .
T-cell subsets in thymuses from GVHR or control chimeras were analyzed 1 wk following ABMT. Table 1 Given that V,6 TCR expression is strongly associated with recognition of I-E and Mls-la antigen (18, 20, 25) , the increased proportions of T cells in thymuses of GVHR chimeras may result from alloreactivity of donor T cells against recipient antigens (I-E and Mls-la) within the thymus.
Vp6' T Cells in the Thymuses of GVHR Chimeras May Be
Reacting Against Recipient (I-E and Mls-1a) Within the Thymus. We examined thymuses from GVHR or control [B10 -AKR] chimeras to identify V,86+ cells in situ. Significant numbers of Vp36+ T cells were present in the GVHR thymus tissue (Fig. 3) , although their precise localization (cortex or medulla) could not be identified. These cells were not seen in thymuses from control chimeras. FACS analysis of these tissues showed that the cell size of the major population in V,06' T cells in thymuses and spleens was greater in GVHR chimeras than in normal donor (B10) mice (Fig. 4) Vp6' SP Thymocytes in GVHR Chimeras 5 wk after ABMT Were Cells that Had Differentiated from Donor BM. Splenic T cells from (B10 x 4R)F1 mice were mixed with T-celldepleted BM cells from B10 mice and inoculated into AKR recipients (mixed chimeras). T cells from (B10 x 4R)F1 mice were assumed not to respond against B10 BM cells or to exert greater influence on reconstitution of recipient thymuses by donor precursors than do B10 T cells. Five weeks following ABMT no differences in thymocyte subpopulations were observed between such mixed chimeras and GVHR chimeras (data not shown). Seven percent of CD4+8-and 14.1% of CD4-8+ SP thymocytes were V,366 (Table 4) , consistent with data presented in Table 3 . (Table 4 ) and thus were considered to be splenic T cells of (B10 x 4R)F1 mice or their direct descendants. However, 5 wk following ABMT, >99%o of cells were Thyl.2+ and <1%
were Kk positive, indicating that most Vp6+ cells in the recipient thymus were indeed derived from B10 BM. Almost identical results were obtained when V,6+ cells in recipient spleens were analyzed 5 wk after ABMT, although a very small proportion of (B10 x 4R)F1 cells persisted (Table 4) .
These results indicate that a substantial number of Vp6+ T cells observed in GVHR chimeras 5 wk following ABMT were not persisting F1 T cells but were cells derived from BM cells that had differentiated in the recipient thymus. Essentially the same results were obtained when BM cells from B1O.AQR and T cells from (B10 x AQR)F1 mice were transplanted into AKR mice (Table 4 ).
DISCUSSION
The mechanism by which GVHR influences hematopoietic and lymphopoietic tissues remains a significant obstacle in the increasing use of ABMT (1) (2) (3) (4) . In this study of a T-cell subpopulation (Vp6+) that reacts against recipient AKR antigens (I-E and Mls-1a) (18, 25) The present findings suggest that the GVHR observed soon after ABMT influences stromal components of recipient thymus that participate in elimination of self-reactive T cells (18, 30) . Although the possibility that GVHR might influence indirectly thymic function (i.e., by means of corticosteroid hormones) (17) A slight degree of GVHR may be of benefit in treatment of leukemias (graft-versus-leukemia phenomena) (2, 32, 33) . Moreover, complete elimination of allogeneic T cells from donor BM inocula appears to increase the rate of failure in allogeneic engraftment (23, 34) . Since chronic GVHR after ABMT is accompanied by complex autoimmunities and chronic immunodeficiencies, our findings may be relevant to the clinical use of ABMT. Given that alternate forms of tolerance induction by clonal anergy (35, 36) and suppressor mechanisms (37) against T cells reactive to recipient antigens have been demonstrated, the relationship among these mechanisms in induction and maintenance of self-tolerance after ABMT should be pursued.
